Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I
J Inherit Metab Dis
.
2017 May;40(3):311-312.
doi: 10.1007/s10545-017-0014-x.
Epub 2017 Feb 3.
Authors
Esteban Alberto Gonzalez
1
2
,
Angela Maria Vicente Tavares
1
3
4
,
Edina Poletto
1
2
,
Roberto Giugliani
2
5
,
Ursula Matte
6
7
,
Guilherme Baldo
1
2
3
Affiliations
1
Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, 90035-903, Porto Alegre, Brazil.
2
Postgraduate Program in Genetics and Molecular Biology, UFRGS, Porto Alegre, Brazil.
3
Postgraduate Program in Physiology-UFRGS, Porto Alegre, Brazil.
4
Ritter dos Reis University Center-UniRitter, Porto Alegre, Brazil.
5
Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
6
Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, 90035-903, Porto Alegre, Brazil.
[email protected]
.
7
Postgraduate Program in Genetics and Molecular Biology, UFRGS, Porto Alegre, Brazil.
[email protected]
.
PMID:
28160112
DOI:
10.1007/s10545-017-0014-x
No abstract available
Publication types
Letter
Comment
MeSH terms
Aortic Diseases
Cardiovascular Diseases
Dilatation
Humans
Losartan*
Mucopolysaccharidosis I*
Substances
Losartan